Rebecca J. Bluett

Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation

Rebecca J. Bluett, Joyonna Gamble‐George, Daniel Hermanson et al. · Translational Psychiatry · 2014 · 152 citations · Full text

Psychopharmacology, Central Anandamide Levels, Cannabinoid Pharmacology +20

Genetic Disruption of 2-Arachidonoylglycerol Synthesis Reveals a Key Role for Endocannabinoid Signaling in Anxiety Modulation

Brian C. Shonesy, Rebecca J. Bluett, Teniel S Ramikie et al. · Cell Reports · 2014 · 151 citations · Full text

Psychopharmacology, Cannabinoid Pharmacology, Social Sciences +23

Endocannabinoid signalling modulates susceptibility to traumatic stress exposure

Rebecca J. Bluett, Rita Báldi, Andre Haymer et al. · Nature Communications · 2017 · 132 citations · Full text

Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors

Gaurav Bedse, Rebecca J. Bluett, Toni A. Patrick et al. · Translational Psychiatry · 2018 · 114 citations · Full text

Therapeutic Endocannabinoid Augmentation, Psychopharmacology, Locomotor Activity +23

Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the Midbrain

Jennifer M. Wenzel, Erik B. Oleson, Willard N. Gove et al. · Current Biology · 2018 · 100 citations · Full text

Cannabis Use, Neurobiological Mechanism, Neuropsychology +14